Skip to main content

Table 1 The clinical manifestation and biochemical characterization of GD, HT and AITD

From: Association of single nucleotide polymorphism rs3792876 in SLC22A4 gene with autoimmune thyroid disease in a Chinese Han population

 

GD pedigree

HT pedigree

AITD pedigrees

 

GD patients

Controls

HT patients

Controls

AITD patients

Controls

Gender (M/F)

45/156 (1:3.47)

136/141 (1:1.04)

8/21 (1/2.62)

18/28 (1:1.56)

54/176 (1:3.25)

153/170 (1:1.11)

Age (year)

43.72 ± 14.31

48.95 ± 16.98

42.45 ± 19.85

47.55 ± 16.75

43.60 ± 15.17

48.40 ± 17.21

TSH (mIU/L)

0.10 (0.06-1.83)

1.26 (0.79-2.06)

2.04 (0.23-9.06)

2.45 (1.45-3.33)

0.23 (0.01-2.32)

1.37 (0.83-2.30)

FT4 (pmol/L)

25.81 ± 18.55

16.64 ± 3.07

18.79 ± 9.87

16.50 ± 2.01

24.91 ± 17.82

16.62 ± 2.94

FT3 (pmol/L)

7.58 ± 6.72

4.17 ± 0.89

4.71 ± 1.89

4.38 ± 0.97

7.21 ± 6.39

4.20 ± 0.90

TPOAb (IU/ml)

368.50 (46.85-1000)

10.10 (10.00-29.20)

1000.00 (458.75-1000.00)

10.60 (10.00-158.50)

503.50 (53.13-1000.00)

10.10 (10.00-33.35)

TgAb (IU/ml)

59.95 (20.00-460.00)

20.00 (20.00-94.70)

80.60 (31.18-3000.00)

20.00 (20.00-45.70)

59.95 (20.00-519.50)

20.00 (20.00-20.00)